MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway

Fubin Ma; Jibin Yao; Xingdong Niu; Junrui Zhang; Donghai Shi; Mingxu Da

doi:10.1016/j.prp.2024.155471

ScienceGate Book Chapters

JOURNAL ARTICLE

MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway

Fubin Ma Jibin Yao Xingdong Niu Junrui Zhang Donghai Shi Mingxu Da

Year: 2024 Journal: Pathology - Research and Practice Vol: 261 Pages: 155471-155471 Publisher: Elsevier BV

DOI: 10.1016/j.prp.2024.155471

Get Full-Text PDF Get Analytical Report

Keywords:

MAPK/ERK pathway Cancer research Kinase Cell growth Cancer Cell cycle Signal transduction Phenotype Gene knockdown Cell Cell biology Apoptosis Chemistry Biology Genetics Gene Biochemistry

Metrics

Cited By

2.40

FWCI (Field Weighted Citation Impact)

Refs

0.81

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Melanoma and MAPK Pathways

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Cancer Mechanisms and Therapy

Health Sciences → Medicine → Pathology and Forensic Medicine

Fungal Biology and Applications

Health Sciences → Medicine → Pharmacology

MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway

Metrics

Citation History

Topics

Related Documents

TREM1 promotes cancer associated malignant phenotype through activated MAPK signaling pathway and predicts poor prognosis in gastric cancer

BRD9 promotes the malignant phenotype of thyroid cancer by activating the MAPK/ERK pathway

HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway

Quercetin Promotes Apoptosis of Gastric Cancer Cells through the EGFR-ERK Signaling Pathway

SPAG6 Promotes Multiple Myeloma Through Activation of the MAPK/ERK Signaling Pathway